Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Hybrid Platform Trial Comparing the Effects of a Prospective Cohort Treated With a Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Patients With Hard-to-heal DFUs and VLUs

NCT07701590 is registered in ClinicalTrials.gov with Capsicure, LLC as lead sponsor.

NCT NCT07701590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07701590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Hybrid Platform Trial Comparing the Effects of a Prospective Cohort Treated With a Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Patients With Hard-to-heal DFUs and VLUs
Lead sponsor
Capsicure, LLC
Phase
Not applicable
Overall status
Recruiting
Start date
June 22, 2026
Completion date
December 20, 2026
Enrollment
147 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer (dfu), venus leg ulcer, wound, foot